Annia Cavazos
Internal Medicine · Lubbock, TXNPI 1356964209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,580, more than ten times the $146 reported in 2023.
Across 81 payments — averaging $42.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$448
- Sanofi$436
- Galderma Laboratories, L.p.$360
- Amgen$287
- Johnson & Johnson$253
- Sun Pharmaceutical Industries Inc.$167
- plus $2K from 14 others
What the payments were for
- Food & beverage$3,26094%
- Education$1996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $448 |
| Sanofi | 4 | $436 |
| Galderma Laboratories, L.p. | 11 | $360 |
| Amgen | 11 | $287 |
| Johnson & Johnson | 12 | $253 |
| Sun Pharmaceutical Industries Inc. | 5 | $167 |
| Arcutis Biotherapeutics, Inc. | 1 | $165 |
| UCB, Inc. | 3 | $163 |
| Novartis | 6 | $160 |
| LEO Pharma Inc. | 1 | $148 |
| Inari Medical, Inc. | 1 | $146 |
| Revance Therapeutics, Inc. | 1 | $125 |
| Boehringer Ingelheim | 1 | $124 |
| Kyowa Kirin, Inc. | 1 | $119 |
| Lilly USA, LLC | 1 | $105 |
| Pfizer | 2 | $79 |
| AbbVie | 3 | $55 |
| Chiesi USA, Inc. | 2 | $47 |
| Organon | 2 | $40 |
| Genentech USA, Inc. | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,459 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 19 | $245,006 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 35 | $2,731 |
| Ketoconazole | 68 | $1,156 |
| Clobetasol Propionate | 19 | $1,102 |
| Fluorouracil | 13 | $820 |
| Halobetasol Propionate | 15 | $782 |
| Hydroxychloroquine Sulfate | 26 | $463 |
| Fluocinonide | 15 | $341 |
| Triamcinolone Acetonide | 21 | $250 |
| Hydrocortisone | 22 | $192 |
| Doxycycline Monohydrate | 11 | $172 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lubbock
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.